83 related articles for article (PubMed ID: 613585)
1. [Central administration of tiamenidine and clonidine in normotensive and chronically renal hypertensive animals].
Lindner E; Schölkens BA
Verh Dtsch Ges Kreislaufforsch; 1977; 43():234. PubMed ID: 613585
[No Abstract] [Full Text] [Related]
2. Cardiovascular withdrawal effects of clonidine and tiamenidine on abrupt cessation of oral treatment in conscious cats.
Finch L; Hicks PE
J Pharm Pharmacol; 1980 Apr; 32(4):272-7. PubMed ID: 6103057
[TBL] [Abstract][Full Text] [Related]
3. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
4. [Various renal effects of the intracarotid injection of Catapresan (S.T.-155)].
Vázquez-León H
Arch Inst Cardiol Mex; 1972; 42(1):106-12. PubMed ID: 5012962
[No Abstract] [Full Text] [Related]
5. Use of transdermal clonidine in chronic hemodialysis patients.
Rosansky SJ; Johnson KL; McConnell J
Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
Ishii R; Tagawa T; Ishida T; Naruse T
Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
[TBL] [Abstract][Full Text] [Related]
7. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension.
Labiós M; Martínez M; Gabriel F; Guiral V; Munoz A; Aznar J
Am J Hypertens; 2004 Sep; 17(9):757-63. PubMed ID: 15363816
[TBL] [Abstract][Full Text] [Related]
8. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
Hohage H; Schlatter E; Greven J
Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
[TBL] [Abstract][Full Text] [Related]
9. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
Haan D
Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
[No Abstract] [Full Text] [Related]
10. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
[TBL] [Abstract][Full Text] [Related]
11. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
Hansson BG; Hökfelt B
Br J Clin Pharmacol; 1981 Jan; 11(1):73-7. PubMed ID: 7011348
[TBL] [Abstract][Full Text] [Related]
12. The use of transdermal clonidine in the hypertensive patient with chronic renal failure.
Lowenthal DT; Saris SD; Paran E; Cristal N
Clin Nephrol; 1993 Jan; 39(1):37-43. PubMed ID: 8428406
[TBL] [Abstract][Full Text] [Related]
13. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
[TBL] [Abstract][Full Text] [Related]
14. [Lowering of intraocular pressure with clonidin].
Edelhauser E; Nemetz U
Klin Monbl Augenheilkd; 1972 Feb; 160(2):188-93. PubMed ID: 5018069
[No Abstract] [Full Text] [Related]
15. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
Morita T; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
[TBL] [Abstract][Full Text] [Related]
16. The effect of the acute intravenous administration clonidine (St 155) on cerebral blood flow in man.
James IM; Larbi E; Zaimis E
Br J Pharmacol; 1970 May; 39(1):198P-199P. PubMed ID: 5420098
[No Abstract] [Full Text] [Related]
17. Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide.
Tavakoli S; Hajrasouliha AR; Jabehdar-Maralani P; Ebrahimi F; Sadeghipour H; Dehghani M; Shafaroodi H; Dehpour AR
Eur J Pharmacol; 2006 Aug; 542(1-3):148-53. PubMed ID: 16824510
[TBL] [Abstract][Full Text] [Related]
18. A new centrally acting antihypertensive (ICI 106270) which separates antihypertensive effects from sedation.
Clough DP; Hatton R; Pettinger SJ
Arzneimittelforschung; 1981; 31(10):1698-703. PubMed ID: 7198445
[TBL] [Abstract][Full Text] [Related]
19. Central cardiovascular effects of clonidine and another imidazoline derivative ST [600] in adult fowls.
Marmo E; Nisticò G; Rossi F; Rotiroti D
Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):1-10. PubMed ID: 625578
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Hanon O; Berrou JP; Negre-Pages L; Goch JH; Nádházi Z; Petrella R; Sedefdjian A; Sévenier F; Shlyakhto EV; Pathak A
J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
